All News

Stephanie White, PharmD, CSP, is presenting at the NCODA Fall Summit in Orlando, Florida.

The adjuvant therapy has demonstrated varied efficacy for patients.

Effectively educating patients about their medications and disease trajectory can improve adherence and outcomes.

These therapies are being investigated in earlier lines, with several new treatments in development.

Benjamin Brown of Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) discusses his own experience as a patient with cancer and how consensus around pharmacogenomic practices can improve the lives of patients.

The agency does not intend to take action against the plaintiffs for the violation of the Federal Food, Drug, and Cosmetic Act, including the compounding of tirzepatide.

The approval marks Abrysvo as the first and only RSV vaccine designated for adults younger than 50 that are at increased risk for LRTD.

Benefits include reducing serious health consequences, such as hospitalization and death, as well as the economic burden on health systems due to influenza infection.

Pharmacists can educate patients about how to recognize unsafe online sources of medications and ensure patients are properly educate on how to administer their medications.

Higher doses of β-blockers are associated with better clinical outcomes in patient with heart failure.

Pharmacists will likely be the first contact for many affected patients, and they should be able to provide evidence-based advice on how to manage their infection.

An overview of current FDA-approved ROS1-targeted therapies.

Cabotegravir long-acting when used for HIV pre-exposure prophylaxis (PrEP) showed adherence, effectiveness, and improvements in quality of life by those who received the injection.

Despite suggestions to the contrary in previously conducted small clinical trials, montelukast did not provide benefit in patients with COVID-19 symptoms.

Ginger Blackmon, PharmD, will discuss enhancing patient cancer care through implementation of medically integrated oncology team and NCODA’s PQI resources.

Pharmacy Times will be at the NCODA Fall Summit in Orlando from October 23 to October 25, 2024.

Dispensing, communicating, and recording information may look different at each center.

Endometriosis is a systemic disease that can affect multiple parts of the body, not just the pelvis.

Comprising most cases of this rare form of lymphoma, it is essential that pharmacists and treatment providers are aware of the health-related burdens patients with these subtypes consistently face.

New recommendations from the American Stroke Association (ASA) emphasize the importance of healthy lifestyle habits and addressing health equity to reduce stroke risk.

The FDA previously accepted the biologic license application for CT-P13 as a subcutaneous formulation.

Pharmacists are positioned to combat the opioid crisis through educating the public and advocating for policy changes to enable harm reduction strategies.

In April 2024, the FDA approved ustekinumab-aekn as a subcutaneous injection for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis.

Women are more likely to face burnout because they are often balancing both workload and family or home life responsibilities.

New ACIP recommendations provide clarity, but questions linger for those aged 60 to 74 years.

The therapy offers new hope in solid tumor treatment with fewer adverse effects.

There are gonadotoxic risks of chemotherapy, radiation, and surgery that are important to discuss with patients.

Multiple P13K inhibitors have showed promise in treating genetically-mutated forms of breast cancer.